Mangoceuticals clarifies GLP-1 weight-management program launch

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/20/2026

1. BRZE
2. SPY
3. AMZN
4. NFLX
5. SPCX
6. RAPP
7. META
8. IRON
9. NVDA
10. ZION

Go back to Mangoceuticals clarifies GLP-1 weight-management program launch

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

November 13, 2025 7:37 PM EST

Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (Mangoceuticals or the Company) is issuing the following clarification regarding its press release issued earlier this morning titled Mangoceuticals Partners with Eli Lilly and Novo Nordisk.

The newly launched Mangoceuticals weight-management programs MangoRx Direct and PeachesRx Direct are licensed and approved to issue, through a third-party provider, valid prescriptions for FDA-approved branded GLP-1 medications, including, when medically appropriate, Zepbound® from Eli Lilly and Wegovy® from Novo Nordisk. These programs allow Mangoceuticals patients to access, for the first time,... More